Background It is said that psychological stressors have risen during the COVID-19 pandemic, which may contribute to suicidality. A few studies were conducted investigating suicidality amid the first wave of the pandemic in Bangladesh, but none of these studies explored the predictive role of the suicidality-related factors (eg, behavior and health-related variables, COVID-19 risk, fear of COVID-19). Thus, this study aimed to investigate the prevalence of suicidality and the predictive models explaining suicidality variance among Bangladeshi young adults during the second wave of the pandemic. Methods An online-based cross-sectional survey was conducted during the second wave of the pandemic (between 1 and 13 April 2021; a year after the pandemic's inception in the country). The survey questionnaire collected information on socio-demographics, behavior and health-related variables, COVID-19 risk, fear of COVID-19, depression, anxiety, and suicidality. A total of 756 data were analyzed (male 59%; mean age 22.24 ±4.39 years), and hierarchical regression was performed considering suicidality as the dependent variable. A p -value <0.05 was set to be statistically significant with a 95% of confidence interval. Results About 8.2% reported having at least suicidal thoughts within the pandemic inception to survey time (one-year suicidal ideation). More specifically, 7.40% had only suicidal ideation, whereas 0.10% planned for suicide, 0.70% attempted suicide. None of the socio-demographic variables was significantly associated with suicidality. Taking drugs, performing less physical activity, poor self-reporting health condition, being comorbid, being at higher COVID-19 risk, having fear of COVID-19 infection, and suffering from depression and anxiety were significantly associated with a higher risk of suicidality. However, the final model including all of the studied variables explained a 17.1% (F=8.245, p <0.001) variance in terms of suicidality. Conclusion Although this study reported a lower severity of suicidality than prior Bangladeshi studies conducted during the first wave of the pandemic, a portion of people are still at risk of suicide and they should be given attention.
Background Given the importance of sleep, several studies were conducted during the first wave of the COVID-19 pandemic in Bangladesh, but no study was conducted during the second wave. Thus, this study assessed the prevalence rate, associated factors, and predictive models of insomnia during the second wave of the COVID-19 pandemic. Methods An online-based cross-sectional survey was conducted during the second wave of the pandemic (within April 1–13, 2021) and collected information on sociodemographic, behavior and health, COVID-19 risk, fear of COVID-19, depression, anxiety, suicidality, and insomnia. A total of 756 data from Bangladeshi young adults (22.24 ± 4.39 years) were finally analyzed. Results About 13% of the participants ( n = 98 out of a total of 756) had the symptoms of insomnia. Insomnia had a significant gender difference, where females were more prone to be insomniac. Besides, middle class, urban residence, smoking status, not engaging in physical exercise, poor health status, and multi-comorbidities were also profoundly associated with insomnia. In addition, fear of COVID-19, COVID-19 risk, and mental health problems (i.e., depression, anxiety, and suicidality) showed a significant relationship in terms of insomnia. A total of 31.2% variance predicting insomnia was identified considering all of the studied variables. Conclusions The prevalence of insomnia reported herein seems relatively lower than the prior studies, but this figure is not neglectable. Thus, the identified associated factors are highly suggested to consider in policy actions with a special focus on mental health problems to elevate the risk of sleep problems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.